Shree Madhav Pharma

Denosumab 60mg Injection is a monoclonal antibody used for the treatment of bone loss and osteoporosis. It contains Denosumab, which works by inhibiting RANKL (Receptor Activator of Nuclear factor Kappa-Β Ligand), a protein essential for the formation, function, and survival of osteoclasts — the cells that break down bone.

By inhibiting RANKL, Denosumab reduces bone resorption and increases bone mass and strength in both cortical and trabecular bone.

Alburel 20% Injection is a sterile, non-pyrogenic solution containing 20% Human Albumin derived from pooled human plasma. Albumin is the main protein in human plasma and plays a crucial role in maintaining oncotic pressure and transporting substances such as hormones, drugs, and enzymes.

Alburel 20% is used primarily as a plasma volume expander in various medical conditions where blood volume replacement is necessary or when hypoalbuminemia (low blood albumin levels) occurs.

Albucel XP 20% Injection is a sterile, pyrogen-free, hyperoncotic solution of Human Albumin, prepared from pooled human plasma. It contains 20 grams of albumin in 100 ml, formulated to restore and maintain plasma volume and oncotic pressure in patients with low blood albumin or blood volume loss.

Albumin is a naturally occurring plasma protein responsible for regulating oncotic pressure and transporting essential substances like hormones, fatty acids, and drugs throughout the body.

Albucel LS 20% Injection is a sterile, pyrogen-free solution of Human Albumin, derived from pooled human plasma. It contains 20% albumin (20g per 100ml), and is used for plasma volume replacement and treatment of hypoalbuminemia in various medical conditions.

Albumin is the main protein in human plasma, responsible for maintaining oncotic pressure, supporting vascular volume, and transporting essential molecules such as hormones, fatty acids, and drugs.

Albucel 20% is a sterile, pyrogen-free solution containing highly purified human albumin derived from pooled human plasma. This hyperoncotic albumin solution helps restore and maintain plasma volume and oncotic pressure in patients with hypoalbuminemia or plasma volume loss due to various clinical conditions.

Albumin is the principal plasma protein responsible for maintaining colloid osmotic pressure and serves as a carrier for many endogenous and exogenous compounds.

Doceaqualip 20mg Injection contains Docetaxel, a semi-synthetic, cytotoxic chemotherapy agent belonging to the taxane family. It is used in the treatment of various solid tumors and works by inhibiting microtubule depolymerization, which disrupts cell division and leads to cancer cell death.

Doceaqualip is formulated using a lipid-based delivery system, which may enhance tolerability and reduce some side effects associated with conventional docetaxel formulations.

Tigecycline 50mg Injection IP is a broad-spectrum antibiotic belonging to the glycylcycline class, structurally related to tetracyclines. It is effective against a wide range of Gram-positive, Gram-negative, and anaerobic bacteria, including multidrug-resistant strains such as MRSA and VRE.

The sterile powder must be reconstituted and diluted before intravenous administration.

Eleftha 440mg contains Trastuzumab, a recombinant humanized monoclonal antibody targeting the HER2 (human epidermal growth factor receptor 2) protein. HER2 overexpression is linked to aggressive forms of breast and gastric cancers. Trastuzumab binds to HER2 receptors on tumor cells, inhibiting proliferation and inducing immune-mediated destruction.

The lyophilized powder must be reconstituted with sterile water before dilution and intravenous infusion.

Eleftha 375mg contains Trastuzumab, a recombinant humanized monoclonal antibody that specifically targets the HER2 (human epidermal growth factor receptor 2) protein. Overexpression of HER2 is associated with aggressive growth in certain breast and gastric cancers. Trastuzumab binds to HER2 receptors on the surface of cancer cells, inhibiting proliferation and promoting immune-mediated cell death.

The lyophilized powder must be reconstituted with sterile water before administration and then diluted for intravenous infusion.

Eleftha 150mg contains Trastuzumab, a recombinant humanized monoclonal antibody targeting the HER2 (human epidermal growth factor receptor 2) receptor. Overexpression of HER2 is associated with aggressive breast and gastric cancers. Trastuzumab binds to HER2 receptors on cancer cells, blocking their growth and promoting immune-mediated destruction.
The lyophilized powder requires reconstitution with sterile water before dilution and intravenous administration.

Deghor 80mg Injection is a synthetic GnRH receptor antagonist used in the treatment of advanced prostate cancer. It works by blocking GnRH receptors in the pituitary gland, resulting in rapid suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion, which lowers testosterone production without the initial surge seen with GnRH agonists.

Degarelix 120mg Injection is a synthetic GnRH receptor antagonist used to reduce testosterone levels in men with advanced prostate cancer. By blocking GnRH receptors in the pituitary gland, degarelix rapidly decreases luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion, leading to reduced testosterone production by the testes without the initial testosterone surge seen with GnRH agonists.

Bortezomib 2mg Injection IP is a potent proteasome inhibitor used in the treatment of multiple myeloma and mantle cell lymphoma. It works by inhibiting the 26S proteasome, leading to apoptosis of malignant cells.

The lyophilized powder must be reconstituted with sterile water before administration, either intravenously or subcutaneously.